News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 05, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Thought Leader Opinion Indicates That There is Significant Commercial Opportunity in Developing Therapies that Can Improve Overall Survival in First-Line Advanced Ovarian Cancer

 Decision Resources Group finds that in addition to an improvement in median overall survival (MOS), delayed disease progression is one of the...

Jun 05, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

U.S. and European Women's Health Imaging System Market Will Be Driven by the Adoption of New Breast Imaging Modalities

 Decision Resources Group finds that the U.S. and European women's health imaging system market will remain stable through 2022. This will be...

Jun 05, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Asia Pacific Spinal Implant and Bone Graft Substitute Market Will More than Double to Nearly $7 Billion by 2022

 Decision Resources Group finds that the market for spinal implants and bone graft substitutes (BGS) in Australia, South Korea, China and India...

Jun 05, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

U.S. Large-Joint Reconstructive Implant Market Will Reach $8.8 Billion by 2022

 Decision Resources Group finds that the United States large-joint reconstructive implant market will grow to a value of $8.8 billion in 2022,...

Jun 04, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Hospital Consolidation Accelerates in New York City Market

 Decision Resources Group finds that hospital consolidation in the New York City market is growing quickly as six hospitals move forward with...

Jun 04, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Surveyed U.S. Retinal Specialists Are Highly Receptive to Pipeline Agents Targeting Geographic Atrophy, the Dry Form of Advanced Age-Related Macular Degeneration

 Decision Resources Group finds that surveyed U.S. retinal specialists are highly willing to prescribe key emerging therapies for the treatment...

Jun 04, 2014, 08:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Decision Resources Group Announces Partnership with Saama Technologies

 Decision Resources Group (DRG), one of the world's leading firms focusing on healthcare insights, data and analytics, and services, today...

Jun 03, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Rheumatoid Arthritis Brands Missing Key Opportunities to Better Engage Patients and HCPs Through Digital Channels

 Manhattan Research's new Digital Competitive Landscape analysis finds that many rheumatoid arthritis (RA) brands are overlooking valuable ways...

Jun 03, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

A Majority of Physicians and Payers Believe that an Unmet Need Exists for Novel Therapies Targeted at Patients with Severe Persistent Refractory Asthma

 Decision Resources Group finds that surveyed physician specialists will welcome the proliferation of asthma therapies that are poised for U.S....

Jun 02, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Surveyed Hematologists in China Expect the Market Entry of Generic Imatinib to Significantly Decrease Glivec's Patient Share in Chronic Myeloid Leukemia

 Decision Resources Group finds that surveyed hematologists in China estimate that Novartis's Glivec (imatinib) will lose nearly half of its...

Jun 02, 2014, 08:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Kyle Bettigole Joins Decision Resources Group as General Counsel

 Decision Resources Group (DRG), one of the world's leading firms focusing on healthcare insights, data and analytics, and services, announced...

May 29, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The European Vascular Access Device Market Will Expand at a Modest 2.5 Percent Compound Annual Growth Rate Through 2022

 Decision Resources Group finds that the vascular access device market of France, Germany, Italy, Spain and the United Kingdom will grow at a...

May 29, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

New Ventricular Assist Device Launches Will Drive the U.S. Cardiac Assist Device Market to $1.5 Billion by 2022

 Decision Resources Group finds that the U.S. cardiac assist device market has gained traction in recent years with product innovations,...

May 29, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Stethoscopes and Smartphones: Physicians Turn to Digital Tools to Boost Patient Outcomes

 As U.S. healthcare providers reorient their practices to meet outcomes-based incentives, many are looking to patient-facing digital tools to...

May 28, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Surveyed Oncologists Indicate Delayed Disease Progression is Among One of the Greatest Unmet Needs in First-Line Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer

Decision Resources Group finds that, in addition to an improvement in median overall survival (MOS), delayed disease progression is one of the...

May 28, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Global Cardiac Rhythm Management Device Market Will Expand Until 2019, Followed by a Decline in the Market

Decision Resources Group finds that the mature global cardiac rhythm management (CRM) device market will be driven by favorable demographics and...

May 27, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Glivec is the Favored First-Line Tyrosine Kinase Inhibitor for Chronic Phase Chronic Myelogenous Leukemia, According to Surveyed European Hematological Oncologists

 Decision Resources Group finds that Novartis's Glivec is the clear agent of choice for first-line treatment of chronic myelogenous leukemia...

May 21, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Gastroenterologists Agree That Efficacy in Maintenance of Remission is the Most Influential Product Attribute When Prescribing a New Drug for Crohn's Disease

Decision Resources Group finds that, when asked to indicate the relative importance of product attributes when prescribing a new drug for Crohn's...

May 21, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Components of Accountable Care Organizations Create Challenges for Branded Acute Coronary Syndrome and Atrial Fibrillation Therapies

 Decision Resources Group finds that managed care organizations and cardiologists alike believe accountable care organizations (ACOs) will...